Treatment of cystic fibrosis: Time for a new paradigm?

Chest

Volumn 136, Issue 5, 2009, Pages 1197-1199

  Andrew, Bush ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE F 18;

CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DISEASE EXACERBATION; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; LONG TERM CARE; POSITRON; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 70449369309     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1523     Document Type: Editorial

References (15)

1. Dodge JA, Lewis PA, Stanton M, et al. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007; 29:522-526
2. Moss RB, Milla C, Colombo J, et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Hum Gene Ther 2007; 18:726-732 (Pubitemid 47378069)
3. Kerem E, Hirawat S, Armoni S, et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008; 372:719-727
4. Frederiksen B, Koch C, Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997; 23:330-335
5. Aaron SD, Vandemheen KL, Ferris W, et al. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. Lancet 2005; 366:463-471 (Pubitemid 41111694)
6. Balfour-Lynn IM, Lees B, Hall P, et al. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. Am J Respir Crit Care Med 2006; 173:1356-1362 (Pubitemid 43900710)
7. Rosenfeld M, Emerson J, Williams-Warren J, et al. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 2001; 139:359-365 (Pubitemid 32889511)
8. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis: the Pulmozyme Study Group. N Engl J Med 1994; 331:637-642
9. Elborn JS, Prescott RJ, Stack BH, et al. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax 2000; 55:355-358
10. Al-Aloul M, Miller H, Alapati S, et al. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 2005; 39:15-20 (Pubitemid 39628598)
11. Ring E, Eber E, Erwa W, et al. Urinary N-acetyl-β-Dglucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation. Arch Dis Child 1998; 78: 540-543 (Pubitemid 28274696)
12. Turvey SE, Cronin B, Arnold AD, et al. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol 2004; 92:426-432 (Pubitemid 39077584)
13. Steinkamp G, Wiedemann B, Rietschel E, et al. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros 2005; 4:41-48 (Pubitemid 40347776)
14. 18FDGPET/ CT imaging of lungs in patients with cystic fibrosis. Chest 2009; 136:1220-1228
15. Johannesson M, Askling J, Montgomery SM, et al. Cancer risk among patients with cystic fibrosis and their first degree relatives. Int J Cancer 2009 [Epub ahead of print]